Seguir
Nikolaos Pyrpyris
Nikolaos Pyrpyris
National and Kapodistrian University of Athens, School of Medicine, First Department of Cardiology
Dirección de correo verificada de uoa.gr
Título
Citado por
Citado por
Año
The effect of SGLT2 inhibitors on the endothelium and the microcirculation: from bench to bedside and beyond
K Dimitriadis, E Adamopoulou, N Pyrpyris, A Sakalidis, I Leontsinis, ...
European Heart Journal-Cardiovascular Pharmacotherapy 9 (8), 741-757, 2023
192023
The common pathobiology between coronary artery disease and calcific aortic stenosis: evidence and clinical implications
T Abdul-Rahman, I Lizano-Jubert, N Garg, S Talukder, PP Lopez, ...
Progress in Cardiovascular Diseases 79, 89-99, 2023
162023
Safety and efficacy of colchicine for the prevention of post-operative atrial fibrillation in patients undergoing cardiac surgery: a meta-analysis of randomized controlled trials
S Agarwal, CW Beard, J Khosla, S Clifton, MF Anwaar, A Ghani, K Farhat, ...
Europace 25 (7), euad169, 2023
132023
LOX-1 receptor: A diagnostic tool and therapeutic target in atherogenesis
N Pyrpyris, K Dimitriadis, E Beneki, P Iliakis, S Soulaidopoulos, P Tsioufis, ...
Current Problems in Cardiology 49 (1), 102117, 2024
82024
Unravelling the effect of renal denervation on glucose homeostasis: more questions than answers?
E Koutra, K Dimitriadis, N Pyrpyris, P Iliakis, C Fragkoulis, E Beneki, ...
Acta Diabetologica 61 (3), 267-280, 2024
72024
A narrative review on exercise and cardiovascular events:“primum non Nocere”
K Dimitriadis, E Bletsa, E Lazarou, I Leontsinis, P Stampouloglou, E Dri, ...
Heart and Mind 6 (3), 127-138, 2022
72022
The potential future role of extensive lipid lowering in ACS patients with the use of PCSK9 inhibitors: early bird catches the worm
K Dimitriadis, N Pyrpyris, K Tsioufis
European Heart Journal-Cardiovascular Pharmacotherapy 10 (2), 85-86, 2024
62024
Coronary sinus narrowing therapy: A “Reducer” for angina and beyond
K Dimitriadis, P Iliakis, N Pyrpyris, E Beneki, P Tsioufis, K Aznaouridis, ...
Cardiovascular Revascularization Medicine, 2023
52023
Transcatheter Tricuspid Valve Interventions: A Triumph for Transcatheter Procedures?
K Dimitriadis, N Pyrpyris, K Aznaouridis, P Iliakis, A Valatsou, P Tsioufis, ...
Life 13 (6), 1417, 2023
52023
Computed tomography angiography identified high-risk coronary plaques: from diagnosis to prognosis and future management
K Dimitriadis, N Pyrpyris, P Theofilis, E Mantzouranis, E Beneki, ...
Diagnostics 14 (15), 1671, 2024
42024
Management of dyslipidemia in coronary artery disease: the present and the future
K Dimitriadis, P Theofilis, P Iliakis, N Pyrpyris, E Dri, A Sakalidis, ...
Coronary Artery Disease, 10.1097, 2024
42024
Atrial functional mitral regurgitation: From diagnosis to current interventional therapies
P Iliakis, K Dimitriadis, N Pyrpyris, E Beneki, P Theofilis, P Tsioufis, ...
Journal of Clinical Medicine 13 (17), 5035, 2024
32024
Optimal management of high bleeding risk patients undergoing percutaneous coronary interventions: Where do we stand?
K Dimitriadis, N Pyrpyris, P Iliakis, P Kanatas, P Theofilis, A Sakalidis, ...
Journal of Cardiology, 2024
32024
RNA in cardiovascular disease: A new frontier of personalized medicine
T Abdul-Rahman, I Lizano-Jubert, ZSB Bliss, N Garg, E Meale, P Roy, ...
Progress in Cardiovascular Diseases, 2024
32024
Intravascular Imaging in Ultra-Low or Zero-Contrast Percutaneous Coronary Interventions: The Time Is Now?
K Dimitriadis, N Pyrpyris, A Papanikolaou, E Beneki, P Tsioufis, ...
Journal of Clinical Medicine 12 (23), 7499, 2023
32023
Increased rhinovirus/enterovirus infections including Ev-D68 in the United States, a challenge for healthcare providers amidst influenza virus infection and the COVID-19 pandemic
T Abdul-Rahman, A Nazir, B Khater, N Pyrpyris, AA Wireko, DG Miteu, ...
Postgraduate Medical Journal 99 (1171), 372-374, 2023
32023
Efficacy of Chronic Use of Sodium–Glucose Co-transporter 2 Inhibitors on the Prevention of Contrast-Induced Acute Kidney Injury in Patients with Type 2 Diabetes Mellitus …
K Dimitriadis, A Vakka, N Pyrpyris, A Apostolos, E Beneki, E Stathopoulou, ...
American Journal of Cardiovascular Drugs 25 (1), 57-69, 2025
22025
ANOCA updated: From pathophysiology to modern clinical practice
K Dimitriadis, N Pyrpyris, A Sakalidis, E Dri, P Iliakis, P Tsioufis, F Tatakis, ...
Cardiovascular Revascularization Medicine, 2024
22024
Proprotein convertase subtilisin/kexin type 9 inhibitors in patients following acute coronary syndromes: from lipid lowering and plaque stabilization to improved outcomes
K Dimitriadis, N Pyrpyris, P Iliakis, E Beneki, E Adamopoulou, ...
Journal of Clinical Medicine 13 (17), 5040, 2024
22024
Gut Microbiome and Its Role in Valvular Heart Disease: Not a “Gutted” Relationship
G Nayak, K Dimitriadis, N Pyrpyris, M Manti, N Kamperidis, V Kamperidis, ...
Life 14 (4), 527, 2024
22024
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20